Safety and Efficacy of the Combination of Sacubitril/Valsartan and SGLT2i in HFrEF Patients (SECSI Registry). Jimenez-Blanco Bravo M, Valle A, Gayan Ordas J, Del Prado Diaz S, et al. J Cardiovasc Pharmacol 2021;78:e662-e668.

Read + Share

Amedeo Smart

Independent Medical Education

Jimenez-Blanco Bravo M, Valle A, Gayan Ordas J, Del Prado Diaz S, et al. Safety and Efficacy of the Combination of Sacubitril/Valsartan and SGLT2i in HFrEF Patients (SECSI Registry). J Cardiovasc Pharmacol 2021;78:e662-e668.
PMID: 34321396